Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company ...

SaverOne has regained compliance with Nasdaq's bid price requirement, closing above $1.00 for ten consecutive days. SaverOne 2014 Ltd. announced that it has regained compliance with Nasdaq's ...

Aptose Biosciences Inc. announced that it has regained compliance with Nasdaq's minimum bid price requirement after its stock closed above $1.00 per share for ten consecutive business days.

announced today that it has regained compliance with Nasdaq’s minimum bid price requirement. The Listing Qualifications Department of The Nasdaq Stock Market confirmed that the closing bid price ...

China SXT Pharmaceuticals, Inc. (Nasdaq: SXTC) (the “Company”), a specialty pharmaceutical company focusing on the research, ...

AirNet Technology (ANTE)announces that Nasdaq has granted the Company an additional 180-day grace period, until September 15, 2025, to regain ...

AirNet remains fully committed to addressing the bid price deficiency during this extended compliance period. If the Company’s closing bid price meets or exceeds $1 per ADS for a minimum of 10 ...

Aptose Biosciences announced it regained compliance with Nasdaq’s minimum bid price requirement, as its shares maintained a closing bid price of $1.00 or grea ...

LLC (“Nasdaq”) notifying the Company that it is in compliance with Nasdaq’s minimum bid price requirement. On March 14, 2025, Nasdaq confirmed that, for ten consecutive business days ...

On March 14, 2025, Nasdaq confirmed that, for ten consecutive business days, the closing bid price of the Company's common shares has been $1.00 per share or greater. Accordingly, the Company has ...